COMMUNIQUÉS West-GlobeNewswire

Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
20/08/2025
Pre-Treatment with blarcamesine entirely prevented Abeta-induced cognitive decline Confirmed significant biomarker-response in hippocampus NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex [...]
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
20/08/2025
The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care BURLINGTON, Mass. [...]
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer
20/08/2025
Experienced commercial and biopharmaceuticals leader to spearhead launch strategy and global market readiness for ersodetug REDWOOD CITY, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“ [...]
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
20/08/2025
YAVNE, Israel, August 20, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in [...]
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
20/08/2025
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that its Board of Directors has [...]
Cytokinetics Names Jim Daly to Board of Directors
20/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors effective August 19, 2025. Mr. Daly [...]
First PRIZM Study Participant Enrolled in Tisento Therapeutics’ Open-Label Extension Study in MELAS
20/08/2025
Participants Who Complete Treatment in Global Phase 2b PRIZM MELAS Study Are Eligible to Enroll CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first participant has [...]
Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy
20/08/2025
New hope for millions of glaucoma patients as funding advances surgical access to the uveoscleral pathway WHITE PLAINS, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a pioneer in bio-interventional ophthalmic [...]
I-Mab Reports Second Quarter 2025 Financial Results and Provides Business Update
20/08/2025
Positive givastomig Phase 1b dose escalation data in combination with immunochemotherapy in patients with 1L gastric cancers presented at ESMO GI 2025 showing 83% ORR at doses selected for ongoing expansion study [...]
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
20/08/2025
DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia
20/08/2025
REYKJAVIK, ICELAND (August 20, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Patrik Ling [...]
Sai Life Sciences secures SBTi validation for near-term climate targets
20/08/2025
HYDERABAD, India, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO) , announced that [...]
337,000 Orion Corporation A shares converted into B shares
20/08/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST 337,000 Orion Corporation A shares converted into B shares In accordance with [...]
Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update
20/08/2025
Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, announces its second quarter 2025 [...]
Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution
20/08/2025
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment [...]
L'hôpital universitaire de Heidelberg élargit son programme de thérapie par particules avec une solution Proteus®ONE
20/08/2025
Louvain-la-Neuve, Belgique, le 20 août 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le [...]
Dallas Premier No Surgery Hair Replacement Folicure Hair Helps Men Reclaim Their Confidence in New Guide to Recognizing When Hair Loss Calls for Action
20/08/2025
Discover Best Dallas Premier No Surgery Hair Replacement guide to identifying hair loss and exploring tailored hair replacement solutions to regain confidence and restore your hairline. Dallas, TX, Aug. 19, 2025 (GLOBE [...]
HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
20/08/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a [...]
CORRECTION – Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
20/08/2025
IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today [...]

Pages